These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38128180)

  • 21. Pharmacokinetics-derived absorbed components responsible for Guizhi-Fuling capsule target PI3K/Akt-Erk to exert an anti-dysmenorrhea effect.
    Zhao Q; Cheng J; Bian X; Wang C; Xu Y; Ding H; Ren H; Zhang Y; Xu M; Shan C; Yan H; Duan J; Qian D; Huang X
    J Ethnopharmacol; 2022 Oct; 297():115525. PubMed ID: 35811027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quality evaluation of guizhi fuling capsule using self-control method of reference Chinese medicine preparation].
    Geng T; Zhang ZJ; Li YJ; Ding G; Bi YA; Wang ZZ; Xiao W
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(21):4127-32. PubMed ID: 25775780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC-OXPHOS axis.
    Jiang R; Chen Z; Ni M; Li X; Ying H; Fen J; Wan D; Peng C; Zhou W; Gu L
    J Transl Med; 2023 Jul; 21(1):504. PubMed ID: 37496051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA THOR promotes ovarian Cancer cells progression via IL-6/STAT3 pathway.
    Ge J; Han T; Shan L; Na J; Li Y; Wang J
    J Ovarian Res; 2020 Jun; 13(1):72. PubMed ID: 32552789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1.
    Li YK; Gao AB; Zeng T; Liu D; Zhang QF; Ran XM; Tang ZZ; Li Y; Liu J; Zhang T; Shi GQ; Zhou WC; Zou WD; Peng J; Zhang J; Li H; Zou J
    J Transl Med; 2024 Jan; 22(1):46. PubMed ID: 38212795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3).
    Kandala PK; Srivastava SK
    BMC Med; 2012 Jan; 10():9. PubMed ID: 22280969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer.
    Devarajan A; Su F; Grijalva V; Yalamanchi M; Yalamanchi A; Gao F; Trost H; Nwokedi J; Farias-Eisner G; Farias-Eisner R; Fogelman AM; Reddy ST
    Cell Death Dis; 2018 Mar; 9(3):392. PubMed ID: 29531225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Multiple Pharmacologic Functions and Mechanisms of Action of Guizhi Fuling Formulation.
    Gao J; Yang J; Lu Z; Dong X; Xu Y
    Evid Based Complement Alternat Med; 2022; 2022():6813421. PubMed ID: 35529925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syringic acid regulates suppression of the STAT3/JNK/AKT pathway via inhibition of human ovarian teratoma cancer cell (PA-1) growth-in vitro study.
    Yang L; Qu C; Jin J; Yang H; Pei L
    J Biochem Mol Toxicol; 2021 Jun; 35(6):1-9. PubMed ID: 33759321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.
    Jia Y; Shi H; Cao Y; Feng W; Li M; Li X
    Life Sci; 2019 Sep; 233():116715. PubMed ID: 31376371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated identification, qualification and quantification strategy for pharmacokinetic profile study of Guizhi Fuling capsule in healthy volunteers.
    Zhong YX; Jin XL; Gu SY; Peng Y; Zhang KR; Ou-Yang BC; Wang Y; Xiao W; Wang ZZ; Aa JY; Wang GJ; Sun JG
    Sci Rep; 2016 Aug; 6():31364. PubMed ID: 27527657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Heat Shock Protein 90 suppresses TWIST1 Transcription.
    Chong KY; Kang M; Garofalo F; Ueno D; Liang H; Cady S; Madarikan O; Pitruzzello N; Tsai CH; Hartwich TMP; Shuch BM; Yang-Hartwich Y
    Mol Pharmacol; 2019 Aug; 96(2):168-179. PubMed ID: 31175180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
    Zhong Y; Le F; Cheng J; Luo C; Zhang X; Wu X; Xu F; Zuo Q; Tan B
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Mechanisms of Guizhi Fuling Wan in Treating Endometriosis: An Analysis Based on TCMSP and DisGeNET Databases.
    Yee JL; Huang CY; Yu YC; Huang SJ
    J Ethnopharmacol; 2024 Jul; 329():118190. PubMed ID: 38614264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis.
    Wei X; Liu Y; Gong C; Ji T; Zhou X; Zhang T; Wan D; Xu S; Jin P; Yang X; Li X; Ma D; Yang Z; Gao Q
    Anticancer Agents Med Chem; 2017; 17(8):1093-1101. PubMed ID: 28002999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells.
    Zhong LX; Li H; Wu ML; Liu XY; Zhong MJ; Chen XY; Liu J; Zhang Y
    J Ovarian Res; 2015 Apr; 8():25. PubMed ID: 25896424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Jagged1/STAT3 signalling in platinum-resistant ovarian cancer.
    Yang J; Xing H; Lu D; Wang J; Li B; Tang J; Gu F; Hong L
    J Cell Mol Med; 2019 Jun; 23(6):4005-4018. PubMed ID: 30993885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.
    Chen MW; Yang ST; Chien MH; Hua KT; Wu CJ; Hsiao SM; Lin H; Hsiao M; Su JL; Wei LH
    Cancer Res; 2017 Apr; 77(8):1955-1967. PubMed ID: 28209618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overcoming cisplatin resistance by targeting the MTDH-PTEN interaction in ovarian cancer with sera derived from rats exposed to Guizhi Fuling wan extract.
    Han L; Cao X; Chen Z; Guo X; Yang L; Zhou Y; Bian H
    BMC Complement Med Ther; 2020 Feb; 20(1):57. PubMed ID: 32066429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6 and Hypoxia Synergistically Promote EMT-Mediated Invasion in Epithelial Ovarian Cancer via the IL-6/STAT3/HIF-1
    Zhang T; Yang J; Sun Y; Song J; Gao D; Huang S; Pang A; Zhang J; Wang J; Wang Y; Li Y
    Anal Cell Pathol (Amst); 2023; 2023():8334881. PubMed ID: 36814597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.